Silk Protein Bioresorbable, Drug-Eluting Ear Tubes: Proof-of-Concept.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30624860.
- Also identified by DOI 10.1002/adhm.201801409 and PMC identifier 6433150.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Otitis media with effusion (OEM) is a common pediatric pathology treated with topical fluoroquinolones (ear drops) and tympanoplasty tube, also referred to as ear tube, implantation for middle ear drainage. Commercially available ear tubes are fabricated using poly (lactic-co-glycolic acid) synthetic materials that are associated with long-complications due to premature extrusion. Resorbable materials have emerged as desirable alternatives to reduce extrusion-related complications, but often limited by fast resorption rates. Therefore, resorbable tubes with long-term functional integrity are required for future clinical translation. In this communication, a proof-of-concept study is reported on a bioresorbable and drug-eluting silk ear tube device. Preliminary in vitro assessments reveal time-dependent drug elution and antimicrobial properties, while maintaining long-term functional integrity in vivo. This report provides evidence of a silk ear tube with potential for future clinical translation and OEM treatment.
Medical subject headings
- Absorbable Implants
- Anti-Bacterial Agents
- Fluoroquinolones
- Otitis Media with Effusion
- Tympanoplasty